Leucine transporters and enzymes (LAT1, BCAT, BCKDC)

Leucine transporters (notably LAT1, LAT2, LAT3, LAT4, B0AT1, etc.) are integral membrane proteins that mediate the uptake of the essential amino acid leucine and other neutral amino acids into cells, using mechanisms like facilitated diffusion or sodium symport. LAT1 is overexpressed in many tumors and is a key therapeutic target. BCAT and BCKDC are the principal enzymes involved in leucine catabolism, converting leucine into intermediate metabolites and ultimately into energy substrates such as acetyl-CoA and succinyl-CoA. Dysregulation of these molecules is implicated in various disease states including cancer, metabolic syndromes, and neurological disorders. Pharmacological targeting includes competitive inhibition, allosteric modulation, and supplement-based strategies.

Other names

Solute Carrier Family 7 Member 5 (SLC7A5)System L TransportersNeutral Amino Acid TransportersL-leucine TransportersBCAT1BCAT2Branched-chain Amino Acid TransaminaseBranched-chain α-ketoacid Dehydrogenase (BCKDC)LeuT (bacterial leucine transporter)

Transporter inhibitors: Block leucine uptake into target cells (anticancer mechanism by starving tumor cells of amino acids). Enzyme modulators: Inhibit or activate BCAT/BCKDC to control leucine catabolism, affecting energy metabolism and mTOR signaling. Substrate competition: Differential amino acid uptake to modulate downstream signaling and metabolism.